Publications by authors named "Isabelle Ray-Coquard"

100Publications

Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment.

Cancer Treat Rev 2020 Nov 21;90:102107. Epub 2020 Sep 21.

Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte (KEM), Essen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2020.102107DOI Listing
November 2020

Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change?

ESMO Open 2020 10;5(5)

MBBS MA FRCP, The Royal Marsden NHS Foundation Trust nd Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2020-000924DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554405PMC
October 2020

Overcoming resistance to PARP inhibitor in epithelial ovarian cancer, are we ready?

EBioMedicine 2020 Nov 7;61:103046. Epub 2020 Oct 7.

Centre Léon Bérard, 28 Prom. Léa et Napoléon Bullukian, Lyon 69008, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2020.103046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553990PMC
November 2020

Risk of death of patients with cancer presenting with severe symptoms of infection, with or without documented COVID-19: In reply to van Dam et al.

Eur J Cancer 2020 11 6;139:68-69. Epub 2020 Sep 6.

Centre Leon Berard, Lyon, France; Universite de Lyon, Lyon, France; Unicancer, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2020.08.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474920PMC
November 2020

Pregnancy in Women with Metastatic Sarcomas.

Oncologist 2020 Sep 19. Epub 2020 Sep 19.

Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/onco.13529DOI Listing
September 2020

Challenges for immunotherapy for the treatment of platinum resistant ovarian cancer.

Semin Cancer Biol 2020 Sep 12. Epub 2020 Sep 12.

Department of Oncology, Hôpitaux Universitaires de Genève, Geneva, Switzerland; Department of Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2020.08.017DOI Listing
September 2020

Comparative analysis of predictive values of the kinetics of 11 circulating miRNAs and of CA125 in ovarian cancer during first line treatment (a GINECO study).

Gynecol Oncol 2020 Oct 22;159(1):256-263. Epub 2020 Jul 22.

EMR3738, Ciblage Thérapeutique en Oncologie, Faculté de Médecine et de Maïeutique Lyon-Sud Charles Mérieux, Université Claude Bernard Lyon 1, Oullins, France, Université de Lyon, Lyon, France; Service d'Oncologie Médicale, CITOHL, Centre Hospitalo-Universitaire Lyon-Sud, Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL), Pierre-Bénite, France, GINECO, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.07.021DOI Listing
October 2020

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).

Authors:
Aline Talhouk Joshy George Chen Wang Timothy Budden Tuan Zea Tan Derek S Chiu Stefan Kommoss Huei San Leong Stephanie Chen Maria P Intermaggio Blake Gilks Tayyebeh M Nazeran Mila Volchek Wafaa Elatre Rex C Bentley Janine Senz Amy Lum Veronica Chow Hanwei Sudderuddin Robertson Mackenzie Samuel C Y Leong Geyi Liu Dustin Johnson Billy Chen Aocs Group Jennifer Alsop Susana N Banerjee Sabine Behrens Clara Bodelon Alison H Brand Louise Brinton Michael E Carney Yoke-Eng Chiew Kara L Cushing-Haugen Cezary Cybulski Darren Ennis Sian Fereday Renée T Fortner Jesús García-Donas Aleksandra Gentry-Maharaj Rosalind Glasspool Teodora Goranova Casey S Greene Paul Haluska Holly R Harris Joy Hendley Brenda Y Hernandez Esther Herpel Mercedes Jimenez-Linan Chloe Karpinskyj Scott H Kaufmann Gary L Keeney Catherine J Kennedy Martin Köbel Jennifer M Koziak Melissa C Larson Jenny Lester Liz-Anne Lewsley Jolanta Lissowska Jan Lubiński Hugh Luk Geoff Macintyre Sven Mahner Iain A McNeish Janusz Menkiszak Nikilyn Nevins Ana Osorio Oleg Oszurek José Palacios Samantha Hinsley Celeste L Pearce Malcolm C Pike Anna M Piskorz Isabelle Ray-Coquard Valerie Rhenius Cristina Rodriguez-Antona Raghwa Sharma Mark E Sherman Dilrini De Silva Naveena Singh Peter Sinn Dennis Slamon Honglin Song Helen Steed Euan A Stronach Pamela J Thompson Aleksandra Tołoczko Britton Trabert Nadia Traficante Chiu-Chen Tseng Martin Widschwendter Lynne R Wilkens Stacey J Winham Boris Winterhoff Alicia Beeghly-Fadiel Javier Benitez Andrew Berchuck James D Brenton Robert Brown Jenny Chang-Claude Georgia Chenevix-Trench Anna deFazio Peter A Fasching María J García Simon A Gayther Marc T Goodman Jacek Gronwald Michelle J Henderson Beth Y Karlan Linda E Kelemen Usha Menon Sandra Orsulic Paul D P Pharoah Nicolas Wentzensen Anna H Wu Joellen M Schildkraut Mary Anne Rossing Gottfried E Konecny David G Huntsman Ruby Yun-Ju Huang Ellen L Goode Susan J Ramus Jennifer A Doherty David D Bowtell Michael S Anglesio

Clin Cancer Res 2020 Oct 17;26(20):5411-5423. Epub 2020 Jun 17.

British Columbia's Gynecological Cancer Research Program (OVCARE), BC Cancer, Vancouver General Hospital, and University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572656PMC
October 2020

Cabozantinib as an emerging treatment for sarcoma.

Curr Opin Oncol 2020 07;32(4):321-331

GINECO and Medical Oncology Department, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000644DOI Listing
July 2020

Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials.

Cancer Treat Rev 2020 Jul 26;87:102040. Epub 2020 May 26.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynaecology, European Competence Center for Ovarian Cancer, Campus Virchow Clinic, 13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2020.102040DOI Listing
July 2020

Rare ovarian tumors: an update on diagnosis and treatment.

Int J Gynecol Cancer 2020 06 26;30(6):879-887. Epub 2020 May 26.

Medical Oncology, Centre Leon Berard, Lyon, Rhône-Alpes, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2020-001235DOI Listing
June 2020

Cabozantinib as an emerging treatment for sarcoma.

Curr Opin Oncol 2020 Jun 5. Epub 2020 Jun 5.

GINECO and Medical Oncology Department, Centre Léon Bérard, Université Claude Bernard Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000644DOI Listing
June 2020

PARP Inhibitors in Ovarian Cancer. Reply.

N Engl J Med 2020 04;382(16):1574-1575

Université Paris Descartes, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc2000644DOI Listing
April 2020

Rare Gynecologic Tumors: Coming of Age.

Gynecol Oncol 2020 04;157(1):1-2

Centre Leon Bèrard, Université Claude Bernard Lyon, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers de l'Ovaire (GINECO), Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2020.03.001DOI Listing
April 2020

[Current advances in immunotherapy in ovarian cancer].

Bull Cancer 2020 Apr 20;107(4):465-473. Epub 2020 Feb 20.

Centre Léon-Bérard, 28, rue Laennec, 69008 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.11.015DOI Listing
April 2020

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

N Engl J Med 2019 12;381(25):2416-2428

From Centre Léon Bérard (I.R.-C., D.P.), University Claude Bernard Lyon 1 (I.R.-C.), and Centre Hospitalier Lyon-Sud (B.Y.), Lyon, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) (I.R.-C., P.P., F.S., C.L.-P., A.L., P.C., M.R., C.D., B.Y., E.P.-L.), Groupe Hospitalier Diaconesses Croix Saint-Simon (F.S.), Hôpital Européen Georges Pompidou (P.C.), Institut Curie, Hôpital Claudius Régaud (M.R.), and Association de Recherche Cancers Gynécologiques (ARCAGY) (E.P.-L.), Paris, Gustave Roussy, Villejuif (P.P.), Centre Eugène Marquis, Rennes (C.L.-P.), Centre Catherine de Sienne Hôpital Privé du Confluent, Nantes (A.L.), and Institut Curie, Hôpital René Huguenin, Saint Cloud (C.D.) - all in France; the Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples (S.P.), University of Milan-Bicocca and European Institute of Oncology IRCCS, and Mario Negri Gynecologic Oncology Group (MANGO) (N.C.), and Fondazione IRCCS Istituto Nazionale Tumori and MITO (D.L.), Milan, and Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, and MITO, Rome (G.S.) - all in Italy; M.D. Anderson Cancer Center Madrid (A.G.-M.), Grupo Español de Investigación en Cáncer de Ovario (GEICO) (A.G.-M., E.M.G.A.), and Hospital Universitario Ramón y Cajal (E.M.G.A.) - all in Madrid; Medical University of Innsbruck, University Clinic for Gynecology and Obstetrics (R.B.), and Arbeitsgemeinschaft Gynäkologische Onkologie Study Group (AGO)-Austria (R.B., A.R.), Innsbruck, and Medical University of Vienna, Vienna (A.R.) - all in Austria; Saitama Medical University International Medical Center, Hidaka (K.F.), Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama-cho (K.F., S.N.), and Hyogo Cancer Center, Akashi (S.N.) - all in Japan; University Hospital Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynecologic Oncology Group (BGOG) - both in Leuven, Belgium (I.V.); Tampere University and University Hospital, Tampere, Finland (J.M.); the Nordic Society of Gynecologic Oncology (NSGO), Copenhagen (J.M.); and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin (J.S.), German Society of Gynecologic Oncology (AGO) (J.S., U.C., F.M., N.G., P.B., A.B., P.H.), Universitätsklinikum Essen (P.B.), and Kliniken Essen Mitte (P.H.), Essen, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden (U.C.), Universitätsklinikum Heidelberg, Heidelberg (F.M.), Universitätsklinikum Ulm, Ulm (N.G.), and Klinikum der Universität München, Munich (A.B.) - all in Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1911361DOI Listing
December 2019

Assessing the performance of indicators during their life cycle: the mixed QUID method.

Int J Qual Health Care 2020 Apr;32(1):12-19

Pôle de Santé Publique, Hospices Civils de Lyon; Univ Lyon, Université Claude Bernard Lyon1, Hesper EA 7425, F - 69003, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/intqhc/mzz090DOI Listing
April 2020

Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis.

Gynecol Oncol 2020 02 18;156(2):377-386. Epub 2019 Nov 18.

Centre de recherche du Centre hospitalier de l'Université de Montreal (CRCHUM), and Institut du cancer de Montréal, Montreal, QC, Canada; Department of Medicine, University of Montreal, Montreal, QC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.11.019DOI Listing
February 2020

Management of Rare Ovarian Cancer Histologies.

J Clin Oncol 2019 09 12;37(27):2406-2415. Epub 2019 Aug 12.

Centre Leon Bèrard, Université Claude Bernard Lyon, Groupe d'Investigateurs Nationaux pour l'Étude des Cancers de l'Ovaire (GINECO), Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02419DOI Listing
September 2019

Early Modeled Longitudinal CA-125 Kinetics and Survival of Ovarian Cancer Patients: A GINECO AGO MRC CTU Study.

Clin Cancer Res 2019 09 1;25(17):5342-5350. Epub 2019 Apr 1.

Université de Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon-Sud, EMR UCBL/HCL 3738, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3335DOI Listing
September 2019

Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?

J Immunother Cancer 2019 03 28;7(1):85. Epub 2019 Mar 28.

Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Cancer Research Center of Lyon (CRCL), Centre Léon Bérard, F-69008, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0549-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437964PMC
March 2019

Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.

Virchows Arch 2019 Jul 9;475(1):85-94. Epub 2019 Feb 9.

Department of Pathology, Hospices Civils de Lyon, Centre de Biologie et de Pathologie Sud, Chemin du Grand Revoyet, Université de Lyon, Université Claude Bernard Lyon I, 69495, Pierre Bénite Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-019-02532-wDOI Listing
July 2019

Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey).

Support Care Cancer 2019 Jul 8;27(7):2517-2524. Epub 2018 Nov 8.

GREPS, Psychology Institute, Lyon 2 University, 5 avenue P. Mendès-France, 69676, Bron, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-018-4536-z
Publisher Site
http://dx.doi.org/10.1007/s00520-018-4536-zDOI Listing
July 2019

Management of relapsed ovarian cancer in routine clinical practice: a case study.

Expert Rev Anticancer Ther 2018 10;18(sup1):9-11

a GINECO/TMRO Network , Centre Léon Bérard & Université Claude Bernard , Lyon , France.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1515630DOI Listing
October 2018

Fertility preservation in women with cancer: a national study about French oncologists awareness, experience, and feelings.

J Assist Reprod Genet 2018 Oct 4;35(10):1843-1850. Epub 2018 Jul 4.

Sorbonne Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP- HP), Hôpital Universitaire Paris Centre, Centre Hospitalier Universitaire (CHU) Cochin, Service d'Histologie-Embryologie-Biologie de la Reproduction, Université Paris Descartes, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10815-018-1251-0
Publisher Site
http://dx.doi.org/10.1007/s10815-018-1251-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150902PMC
October 2018

Gynecological sarcomas: what's new in 2018, a brief review of published literature.

Curr Opin Oncol 2018 07;30(4):246-251

Department of Medical Oncology, Centre Léon Bérard, Lyon Cedex.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000462DOI Listing
July 2018

Options for treating different soft tissue sarcoma subtypes.

Future Oncol 2018 May;14(10s):25-49

Department of Medical Oncology, Sarcoma Center, West German Cancer Center, University of Duisburg-Essen, Essen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0076DOI Listing
May 2018

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial.

Am J Clin Oncol 2018 Nov;41(11):1094-1100

*Medical Oncology Department ‡Methodology and Biostatistics Unit #Clinical Research Unit, Centre Oscar Lambret ∥Medical Oncology, Institut Claudius Regaud, Cedex †Medical Oncology Department, Villejuif §Medical Oncology Department, Centre Léon Bérard, Lyon ¶Medical Oncology Department, Institut Paoli Calmette, Marseille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000430DOI Listing
November 2018

High proportion of abnormal pap smear tests and cervical dysplasia in women with cystic fibrosis.

Eur J Obstet Gynecol Reprod Biol 2018 Feb 9;221:40-45. Epub 2017 Dec 9.

Hospices Civils de Lyon, Cystic Fibrosis Adult Reference Center, Department of Internal Medicine, Groupe Hospitalier Sud, F-69495, Pierre Benite Cedex, France; Univ. Lyon, Université Claude Bernard Lyon 1, HESPER EA 7425, F-69008 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2017.12.005DOI Listing
February 2018

Soft Tissue and Uterine Leiomyosarcoma.

J Clin Oncol 2018 01 8;36(2):144-150. Epub 2017 Dec 8.

Suzanne George, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; César Serrano, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain; Martee L. Hensley, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY; and Isabelle Ray-Coquard, Centre Leon Berard and University Claude-Bernard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.9845DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759317PMC
January 2018

Trabectedin mechanism of action and platinum resistance: molecular rationale.

Future Oncol 2017 Oct 11;13(23s):17-21. Epub 2017 Oct 11.

Département de Cancérologie Médicale, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0318DOI Listing
October 2017

Cancers de l’ovaire BRCA muté : consultation d’oncogénétique et prescription des inhibiteurs de PARP.

Bull Cancer 2017 May;104 Suppl 1:S16-S23

Département d'oncologie médicale, centre Léon-Bérard, 28, rue Laennec, 69008 Lyon et university Claude-Bernard, Lyon I, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(17)30158-3DOI Listing
May 2017